Brain Imaging and Treatment Studies of the Night Eating Syndrome

Completed · Phase 3

Conditions studied: Night Eating Syndrome

In brief

The purpose of this study is to determine the effectiveness of the anti-depressant Lexapro in the treatment of the Night Eating Syndrome.

Key facts

Study ID

NCT01401595

Run by

University of Pennsylvania

People needed

87

Starts

2009-12-01

Expected to finish

2011-09-01

Last updated by the study team

2020-07-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• men and women suffering from NES
• ages 18 to 70 years
• BMI greater than 18.5 kg/m2

You may not qualify if…

• Children or adolescents <18 years
• persons older than 70
• patients with diabetes mellitus
• thyroid disease and other endocrine and metabolic disorders
• use within the past month of any psychotropic medication, oral steroids, diuretics or hypnotics
• current anorexia nervosa or bulimia nervosa
• participation in an organized weight reduction program
• use of antiobesity medication
• an occupation that involves night shifts or other unusual time requirements -Major Depressive Disorder (judged severe)
• Bipolar Disorder
• suicidal risk
• current or past psychosis
• substance use or abuse disorder within the past 6 months

Where it is running

• The Center for Weight and Eating Disorders — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.